Literature DB >> 17354256

Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma.

T Görögh1, J B Weise, C Holtmeier, P Rudolph, J Hedderich, S Gottschlich, M Hoffmann, P Ambrosch, K Csiszar.   

Abstract

Members of the lysyl oxidase family (LOX) are copper and lysyl-tyrosine quinone cofactor-containing amine oxidases that are important for the assembly and maintenance of components of the extracellular matrix. Our previous results demonstrated that a novel member, LOXL4, is overexpressed in head and neck squamous cell carcinoma (HNSCC) compared to normal squamous epithelium. Results of the current study showed overexpression of the LOXL4 transcript in 74% (46 of 62) of invasive HNSCC tumours and 90% of both primary and metastatic HNSCC cell lines. Significant correlation was found between LOXL4 expression and local lymph node metastases versus primary tumour types (p<0.01) and higher tumour stages (p<0.01). Immunocytochemistry demonstrated cellular overexpression of the LOXL4 protein that correlated with the increased mRNA transcription in HNSCC cells. HNSCC cell lines displayed in significant subset of nuclei increased copies of the LOX4 gene locus on chromosome 10q24, demonstrated by fluorescence in situ hybridization (FISH). Extensive metaphase cytogenetic analysis was performed on UTSCC19A cells, identifying an isochromosome i(10)(q10). Taken together, these results highlight LOXL4 expression as a distinctive trait and suggest a functional role for LOXL4 in the molecular pathogenesis of invasive head and neck carcinomas. Copyright (c) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17354256     DOI: 10.1002/path.2137

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  17 in total

Review 1.  Human copper-dependent amine oxidases.

Authors:  Joel Finney; Hee-Jung Moon; Trey Ronnebaum; Mason Lantz; Minae Mure
Journal:  Arch Biochem Biophys       Date:  2014-01-06       Impact factor: 4.013

2.  Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer.

Authors:  Shulamit Sebban; Regina Golan-Gerstl; Rotem Karni; Olga Vaksman; Ben Davidson; Reuven Reich
Journal:  Clin Exp Metastasis       Date:  2012-07-18       Impact factor: 5.150

3.  Characterisation of seven newly established head and neck squamous cell carcinoma cell lines.

Authors:  Tibor Görögh; Elgar Susanne Quabius; Patrick Meyer; Markus Hoffmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-04       Impact factor: 2.503

4.  LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis.

Authors:  Mengxin Tian; Weiren Liu; Lei Jin; Xifei Jiang; Liuxiao Yang; Zhenbin Ding; Yinghao Shen; Yuanfei Peng; Dongmei Gao; Lixin Li; Jian Zhou; Shuangjian Qiu; Zhi Dai; Jia Fan; Yinghong Shi
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

5.  LOX family enzymes expression in vaginal tissue of premenopausal women with severe pelvic organ prolapse.

Authors:  May Alarab; Maria A T Bortolini; Harold Drutz; Stephen Lye; Oksana Shynlova
Journal:  Int Urogynecol J       Date:  2010-06-18       Impact factor: 2.894

6.  High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.

Authors:  Argyrios Chronopoulos; Amanda Tang; Ekaterina Beglova; Philip C Trackman; Sayon Roy
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

7.  Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway.

Authors:  Rong-kun Li; Wen-yi Zhao; Fang Fang; Chun Zhuang; Xiao-xin Zhang; Xiao-mei Yang; Shu-heng Jiang; Fan-zhi Kong; Lin Tu; Wen-ming Zhang; Sheng-li Yang; Hui Cao; Zhi-gang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-14       Impact factor: 4.553

Review 8.  Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.

Authors:  Philip C Trackman
Journal:  Expert Opin Ther Targets       Date:  2016-03-03       Impact factor: 6.902

Review 9.  The rationale for targeting the LOX family in cancer.

Authors:  Holly E Barker; Thomas R Cox; Janine T Erler
Journal:  Nat Rev Cancer       Date:  2012-07-19       Impact factor: 60.716

10.  Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation.

Authors:  Carmen Chak-Lui Wong; Daniele M Gilkes; Huafeng Zhang; Jasper Chen; Hong Wei; Pallavi Chaturvedi; Stephanie I Fraley; Chun-Ming Wong; Ui-Soon Khoo; Irene Oi-Lin Ng; Denis Wirtz; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.